Article
Phenotype and engraftment potential of cytokine-mobilized peripheral blood mononuclear cells.
Current opinion in hematology - 1 May 1997
Mielcarek M, Torok-Storb B
Abstract excerpt
Cytokine-mobilized peripheral blood stem cell products are increasingly used for hematopoietic reconstitution after myeloablative therapy. Favorable engraftment kinetics, the ease of harvest, and the large number of CD34+ cells obtained that allow for graft manipulations (ie, tumor cell or T-cell depletion) have made this stem cell source an attractive alternative to marrow. More recent data suggest that in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
